文献速递妇产影像泌尿生殖MRPET

宫颈癌淋巴结转移评估:T2/DWI MRI融合与标准MRI及18F-FDG PET/CT的对比

Evaluating lymph node metastases in cervical cancer: the added value of T2/DWI MRI fusion compared to standard MRI alone and 18 F-FDG PET/CT.
PubMed 文献 · Abdom Radiol (NY) · 2026-03-09

回顾性单中心研究纳入69例经组织学确诊的宫颈癌患者,评估T2加权与DWI融合MRI对转移性淋巴结的诊断增益,并与标准MRI及18F-FDG PET/CT比较。融合MRI在16/69例(23.2%)中检出标准MRI未发现的额外淋巴结(p<0.001);较PET/CT,融合MRI在11例(15.9%)中检出或更准确表征PET/CT漏诊或误判的淋巴结,仅1例(1.4%)PET/CT更优(p=0.006)。作者认为融合技术改善了淋巴结检出与表征。

要点

  • T2/DWI融合MRI可在23.2%(16/69)患者中检出标准MRI遗漏的淋巴结(p<0.001)。
  • 融合MRI较PET/CT在15.9%(11/69)患者中检出或更准确表征淋巴结,PET/CT仅1.4%(1/69)更优(p=0.006)。
  • 融合技术为常规影像协议提供无创、可及且高效的增强手段,可能影响治疗计划。

核心结论

  • T2加权与DWI序列融合可提高宫颈癌分期中转移性淋巴结的检出和表征,在部分病例中优于标准MRI和PET/CT。

研究设计与样本

  • 回顾性单中心研究,纳入69例经组织学确诊的宫颈癌患者,均行盆腔MRI(含T2加权和DWI序列)及18F-FDG PET/CT;由经验丰富的放射科医师审阅融合图像,记录常规MRI、融合MRI和PET/CT检出的淋巴结数目和位置;采用McNemar检验,p<0.05为差异有统计学意义。

临床应用与阅片要点

  • 作者认为该技术为常规影像协议提供了无创、可及且高效的增强手段,可能影响治疗计划并改善患者结局。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To evaluate the added diagnostic value of T2-weighted and diffusion-weighted imaging (DWI) fusion in MRI for detecting metastatic lymph nodes in cervical cancer, and to compare this fusion technique to 18 F-FDG PET/CT in terms of sensitivity and specificity.

METHODS: In this retrospective single-center study, 69 patients with histologically confirmed cervical cancer underwent pelvic MRI, including T2-weighted and DWI sequences, as well as 18 F-FDG PET/CT. Fusion images combining T2 and high b-value DWI were generated and reviewed by experienced radiologists. The number and location of lymph nodes detected with conventional MRI, fused MRI, and PET/CT were recorded. Statistical analysis was performed using McNemar's test, with p < 0.05 considered statistically significant.

RESULTS: Fusion MRI identified additional lymph nodes in 16 of 69 patients (23.2%) that were not detected on MRI alone (p < 0.001). When comparing fusion MRI to PET/CT, 11 (15.9%) patients had lymph nodes detected or more accurately characterized by fusion MRI that PET/CT missed or misinterpreted, while only 1 case (1.4%) was better identified by PET/CT (p = 0.006).

CONCLUSION: Fusion of T2-weighted and DWI MRI sequences improves the detection and characterization of metastatic lymph nodes in cervical cancer staging, surpassing both standard MRI and PET/CT in selected cases. This technique offers a non-invasive, accessible, and efficient enhancement to conventional imaging protocols, with the potential to influence treatment planning and improve patient outcomes.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Paiva Santos J, Prata R, Serrado MA, et al. Evaluating lymph node metastases in cervical cancer: the added value of T2/DWI MRI fusion compared to standard MRI alone and 18 F-FDG PET/CT. Abdom Radiol (NY). 2026. PMID: 41801385. doi:10.1007/s00261-026-05415-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。